4 Readmission Predictors after Successful TAVR

4 Readmission Predictors after Successful TAVRReadmissions are frequent after cardiovascular procedures and they significantly increase healthcare costs. Data on readmission need within the first month after successful transcatheter aortic valve replacement (TAVR) are limited.

 

The registry included all TAVR patients surviving index hospitalization between January and February 2013 for readmission incidence, predictors, causes and costs within 30 days.

 

Of 12,221 included patients, 2,188 (17.9%) required readmission within 30 days.

 

Readmission predictors were:

  • length of stay longer than 5 days during index hospitalization
  • kidney injury (both acute and chronic)
  • transapical access
  • chronic lung disease

 

61.8% of these was due to non-cardiac causes and the remaining 38.2% was due to cardiac causes. Respiratory causes (14.7%), infections (12.8%), bleeding (7.6%) and peripheral vascular disease (4.3%) were the most common among non-cardiac causes, while heart failure (22.5%) and arrhythmia was the most common among cardiac causes (6.6%).

 

Readmissions median length was four more days.

 

Conclusion

Readmissions at 30 days after TAVR are frequent and are associated with comorbidities, access site and complications during index hospitalization. These predictors could alert about patients at high risk of readmission and prevent major complications.  

 

Original Title: Thirty-Day Readmissions after Transcatheter Aortic Valve Replacement in the United States. Insights from the Nationwide Readmissions Database.

Reference: Dhaval Kolte et al. Circ Cardiovasc Interv. 2017 Jan;10(1).


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...

TAVI and Hypertrophic Cardiomyopathy: An Increasingly Common Association

Stenosis is a common disease affecting 5% of the elderly population. It is associated with hospitalizations, poor quality of life, and mortality.  The association between...

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...